Table 4.
Frequency of extranodal lymphoma at different sites (Berlin 1994–2003)
| Brain (n = 31) | Testis (n = 61) | Lung (n = 79) | Bone marrow (n = 1996) | Stomach (n = 855) | Small intestine (n = 71) | Large intestine (n = 102) | Spleen (n = 128) | Skin (n = 427) | Liver (n = 135) | |
|---|---|---|---|---|---|---|---|---|---|---|
| DLBCL | 25 | 57 | 22 | 66 | 238 | 30 | 32 | 21 | 78 | 52 |
| TCRBCL | – | – | – | 7 | – | – | – | 3 | – | 9 |
| FL | 1 | – | 2 | 168 | 16 | 3 | 3 | 20 | 91 | 11 |
| B-CLL | 1 | – | 2 | 656 | 12 | – | 4 | 10 | 7 | 13 |
| PL | 3 | – | – | 473 | – | – | – | 1 | 2 | 4 |
| MZL | – | – | 40 | 17 | 577 | 4 | 12 | 18* | 12 | 6 |
| MCL | – | – | 3 | 107 | 7 | 7 | 41 | 19 | 6 | 3 |
| LPL | – | – | 3 | 122 | – | – | 2 | 13 | 5 | – |
| HCL | – | – | – | 112 | – | – | – | 6 | – | 1 |
| B-ALL | – | 1 | – | 78 | – | – | – | 1 | – | 2 |
| BL | – | 1 | – | 4 | – | 3 | 2 | – | 2 | 5 |
| cHL | – | – | 3 | 52 | – | – | – | 3 | 10 | 10 |
| B-NHL total (%) | 30/31 (97%) | 59/61 (97%) | 75/79 (95%) | 1862/1996 (93%) | 850/855 (99%) | 47/71 (66%) | 96/102 (94%) | 115/128 (90%) | 213/427 (50%) | 116/135 (86%) |
| pTCL | 1 | – | 3 | 93 | 4 | 6 | 6 | 12 | 94 | 13 |
| NK/T | – | 1 | – | – | – | 2 | – | – | 2 | – |
| T-ALL | – | 1 | – | 29 | – | – | – | – | 9 | – |
| ALCL | – | – | 1 | 8 | 1 | 6 | – | – | 26 | 5 |
| Enteropathy-type TCL | – | – | – | – | – | 10 | – | – | – | – |
| HSTCL | – | – | – | 5 | – | – | – | 1 | – | 1 |
| MF | – | – | – | – | – | – | – | – | 83 | – |
| T-NHL total (%) | 1/31 (3%) | 2/61 (3%) | 4/79 (5%) | 134/1996 (7%) | 5/855 (1%) | 24/71 (34%) | 6/102 (6%) | 13/128 (10%) | 214/427 (50%) | 19/135 (14%) |
*Including nine cases of splenic marginal zone lymphoma (SMZL)